About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 13845 record(s)
Req # A-2020-000367
All records created since March 1, 2020 which have as their chief topic, the department's administration and discharge of its responsibilities under the Access to Information Act.Organization: Health Canada
July 2020
Req # A-2020-000383
Monthly totals for all fields that can be aggregated pertaining to production data, as it relates to the monthly reporting provided to Health Canada by cannabis Licensed Producers from January 01, 2018 to June 15, 2020.Organization: Health Canada
July 2020
Req # A-2020-000581
Documents regarding the Gardasil vaccine in relation to the decision to grant Gardasil Priority Review status, approval, communications between Health Canada (HC) and Merck Frosst Canada Ltd, and communications between HC and United States Food and…Organization: Health Canada
July 2020
Req # A-2019-001951
Adverse Reaction Report (AER). Report numbers: E2B_02061972, E2B_02332998, E2B_02317541, E2B_02318615.Organization: Health Canada
July 2020
Req # A-2019-002084
Adverse Reaction Report (AER). Report number: E2B_02693038.Organization: Health Canada
July 2020
Req # A-2020-000066
Adverse Reaction Report (AER) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report numbers: E2B_02564415, E2B_02564522, E2B_02567164, E2B_02564513, E2B_02567215, E2B_02564869, E2B_02565020, E2B_02564929, E2B_025648+C29:C3363, E2B_02565199, E2B_02564584,…Organization: Health Canada
July 2020
Req # A-2020-000150
Adverse Reaction Report (AER). Report numbers: E2B_02972734, E2B_02974799.Organization: Health Canada
July 2020
Req # A-2020-000153
Adverse Reaction Report (AER). Report numbers: E2B_02866495, E2B_02866496.Organization: Health Canada
July 2020
Req # A-2020-000172
Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02985257.Organization: Health Canada
July 2020
Req # A-2020-000182
All documents in the Management of Executive Correspondence System (MECS) for the following file: 19-075631-61. Subject: Meeting with Innovative Medicines Canada.Organization: Health Canada
July 2020